Trailing-twelve-month (TTM) revenue is $141.35 Million with a year-over-year growth of +8.85%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2025Period ended 2025-09-30 | $37,329,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q2 FY2025Period ended 2025-12-31 | $34,504,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-13 |
| Q3 FY2025Period ended 2026-03-31 | $35,295,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-19 |
| Q4 FY2025Period ended 2026-06-30 | $34,225,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-28 |
| TTM revenue | $141,353,000 |
Current P/S: $8,848,073 market capitalization ÷ $141,353,000 TTM revenue = 0.06x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:05:07.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2025 (2026-06-30): $34.23M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:12:50.016Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2013-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2013-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20112012-06-30 · USD | FY20122013-06-30 · USD |
|---|---|---|
| Branded Products | $2M | $1M |
| Patent And Trademark Licensing | $8M | $5M |
| Private Label Contract Manufacturing | $63M | $57M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20112012-06-30 · USD | FY20122013-06-30 · USD |
|---|---|---|
| Outside United States | $29M | $26M |
| U S | $43M | N/A |
$141.35M
$141.35 Million
+8.85%
vs. $129.86M a year ago (TTM)
(4.56%)
5 Year compound annual growth rate
1 Year
+8.85%
3 Year
(2.82%)
5 Year
(4.56%)
10 Year
+2.16%
15 Year
+6.38%
20 Year
+1.79%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $141.35M | +$11.49M | +8.85% |
| 2024 | $129.86M | +$16.06M | +14.12% |
| 2023 | $113.80M | ($40.22M) | (26.11%) |
| 2022 | $154.01M | ($16.95M) | (9.91%) |
| 2021 | $170.97M | ($7.55M) | (4.23%) |
| 2020 |
TTM Growth
+8.85%
3-Year CAGR
(2.82%)
5-Year CAGR
(4.56%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T19:12:50.016Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $178.52M |
| +$59.64M |
| +50.17% |
| 2019 | $118.88M | ($19.41M) | (14.04%) |
| 2018 | $138.29M | +$5.85M | +4.42% |
| 2017 | $132.44M | +$10.49M | +8.60% |
| 2016 | $121.95M | +$7.75M | +6.78% |
